Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Diagnostics (Basel, Switzerland)|April 12, 2025
[18F]FDG PET/CT of Langerhans Cell Histiocytosis with Vertebra PlanaTilman Speicher, Moritz B Bastian, Konstantinos Christofyllakis, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid CancerFlorian Rosar, Caroline Burgard, Maximilian Linxweiler, et al.
Clinical Nuclear Medicine|February 9, 2023
New Horizons in Radioligand Therapy: 161Tb-PSMA-617 in Advanced mCRPCFlorian Rosar, Stephan Maus, Andrea Schaefer-Schuler, et al.
Clinical Nuclear Medicine|April 30, 2025
Superior Response of CAP-PRRT of G3 NET When Switching to the Somatostatin Receptor Antagonist LM3: Intraindividual Proof-of-conceptTilman Speicher, Caroline Burgard, Florian Rosar, et al.
Clinical Nuclear Medicine|December 3, 2024
First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3)Tilman Speicher, Caroline Burgard, Moritz Bastian, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 30, 2026
FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Moritz B Bastian, Ionas Kyriakou, Florian Rosar, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Advancing patient education in PRRT through large language models: challenges and potentialTilman Speicher, Moritz B Bastian, Arne Blickle, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [18F]FDG PET/CTMoritz B Bastian, Arne Blickle, Caroline Burgard, et al.
Pageof 7